Enhanced potency of intravenous, but not intrathecal, morphine and morphine-6-glucuronide after burn trauma

Related Experiment Videos

A Langlade1, D B Carr, A Serrie

  • 1Department of Anesthesia, Massachusetts General Hospital, Boston 02114.

Life Sciences
|January 1, 1994
PubMed

Insights

This study on acute thermal trauma in rats found that morphine and morphine-6-glucuronide potency varied by administration route after injury. Intravenous administration potency increased, while intrathecal potency decreased.

Area of Science:

  • Pharmacology
  • Pain Management
  • Toxicology

Background:

  • Opioids like morphine are common analgesics.
  • Morphine-6-glucuronide (M6G) is an active metabolite of morphine.
  • Understanding opioid efficacy in trauma is crucial for pain management.

Purpose of the Study:

  • To compare the analgesic effects of morphine (M) and morphine-6-glucuronide (M6G).
  • To investigate the influence of acute thermal trauma on opioid potency.
  • To evaluate the impact of different administration routes (intrathecal vs. intravenous) on M and M6G efficacy.

Main Methods:

  • Utilized a rat model of acute thermal trauma.
  • Administered M or M6G via intrathecal (IT) or intravenous (i.v.) routes.
  • Compared drug potency in burned rats versus sham-burned controls.

Main Results:

  • In non-injured rats, M6G was less potent than M i.v. but tended to be more potent IT.
  • Thermal injury increased i.v. potency for both M and M6G.
  • Thermal injury decreased (M) or tended to decrease (M6G) IT potency.

Conclusions:

  • Opioid potency is significantly altered by acute thermal trauma.
  • Route of administration critically influences M and M6G efficacy post-injury.
  • Changes in potency may involve altered pharmacokinetics or peripheral opioid receptor activation.

Related Concept Videos